首页 | 本学科首页   官方微博 | 高级检索  
检索        

癌性胸液过继性免疫治疗的实验与临床研究
引用本文:韩葆惠,贾友明.癌性胸液过继性免疫治疗的实验与临床研究[J].中华结核和呼吸杂志,1995,18(2):91-93.
作者姓名:韩葆惠  贾友明
作者单位:上海胸科医院,上海医科大学附属中山医院
摘    要:对24例癌性胸腔积液患者自体胸液中的肿瘤浸润淋巴细胞(TIL)在体外经小剂量重组白细胞介素2(rIL2)诱导、扩增、测定了培养前后淋巴细胞亚群CD3、CD4、CD8、CD16、IL2R水平,天然杀狎细胞(NK)活性的改变,并对(TIL/rIL2)治疗前后胸液病理细胞、癌胚抗原(CEA)的变化进行动态观察。结果表明:胸液TIL经培养、扩增后CD8、CD16、NK活性显著升高,胸液CEA水平不同程度的

关 键 词:白细胞介素2  胸膜积液    免疫疗法

The adoptive immunotherapyof malignant pleural ef-fusion with TIL
/rIL. Han Baohui, Jia Youming,Zhou Min,et al..The adoptive immunotherapyof malignant pleural ef-fusion with TIL[J].Chinese Journal of Tuberculosis and Respiratory Diseases,1995,18(2):91-93.
Authors:/rIL Han Baohui  Jia Youming  Zhou Min  
Institution:Shanghai Chest Hospital 200030
Abstract:IL of 24 patients with mahgnant pleural effusionswere induced and expanded in vitro. The phenotype oflymphocytes IL2R , NK cytotoxicity activity were anal-ysed in fresh and activated TIL. CEA and cytology ofmalignant pleural effusion were detected before and aftertreatment with TIL/rIL2. The resuhs indicated : CD_4CDs. IL2R , NK activity increased markedly , CEA leveldecreased in all of the patients, tumor cells disappearedin some patients. The pleural effusion disappeared in63%. The total effective rate of the treatment is 79%.No serious toxicity and side effects were found in 1 to 6months period of following-up after treatment.
Keywords:Lymphocytes  tumor infiltratingInterleukin 2 Pleural effusion Immunotherapy  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号